Immunogenicity 11062
Sample ID
3678
Response
Negative
Tumor Type
Melanoma
Gene Symbol
SLC50A1
Transcript ID
None
HLA INFO
A*02:01
TCR INFO
No TCR info found!
Full length protein sequence (167 aa)
MEAGG
1
FLDSL
6
IYGAC
11
VVFTL
16
GMFSA
21
GLSDL
26
RHMRM
31
TRSVD
36
NVQFL
41
PFLTT
46
EVNNL
51
GWLSY
56
GALKG
61
DGILI
66
VVNTV
71
GAALQ
76
TLYIL
81
AYLHY
86
CPRKA
91
KVIQT
96
KSTQC
101
LSYPL
106
TIATL
111
LTSAS
116
WCLYG
121
FRLRD
126
PYIMV
131
SNFPG
136
IVTSF
141
IRFWL
146
FWKYP
151
QEQDR
156
NYWLL
161
QT
166
Mutation Information
DNA mutation:
None
Peptide Range:
110 ~ 134
Mut AA position:
122 (13 in Wild Type peptide)
Alignment
Wild Type:
"LTIATLLTSASWCLYGFRLRDPYIM
||||||||||||.||||||||||||
Mutant:
LTIATLLTSASWSLYGFRLRDPYIM"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) SLC50A1
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay